Bionik Laboratories Corp. Bionik Laboratories Corp.

Bionik Laboratories Corp.

BNKL

Rank in Stocks #35006
Bionik Laboratories Corp. operates as a robotics firm, focusing on the... Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InMotion ARM, an intelligent and interactive therapeutic system grounded in scientific evidence, adept at perceiving patient movements and physical restrictions. Additionally, the InMotion ARM/HAND is offered to facilitate therapies requiring reaching with grasping and releasing actions, alongside individual hand manipulations. Rounding out their offerings is the InMotion Connect platform, which integrates a hardware unit that interfaces with an InMotion Robot, coupled with a subscription for the InMotion Connect Pulse service. Established in 2010, Bionik Laboratories Corp. maintains its principal operations in Watertown, Massachusetts.
Share Price
$0.0001
Last synced: 2026-11-13
Market Cap
$696.83
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Bionik Laboratories Corp. (BNKL)

Category

Healthcare
EPS for Bionik Laboratories Corp. (BNKL)
EPS as of March 2023 TTM: $-0.73
According to Bionik Laboratories Corp.'s latest financial reports, its current EPS (TTM) is $-0.73. At the end of 2023 the company had an EPS of $-0.72, an increase over its 2022 EPS of $-1.78.
EPS history for Bionik Laboratories Corp. from 2011 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.73 1.39%
2023 $-0.72 -59.55%
2022 $-1.78 -33.08%
2021 $-2.66 -52.50%
2020 $-5.60 25.28%
2019 $-4.47 -79.57%
2018 $-21.88 240.28%
2017 $-6.43 -396.31%
2016 $2.17 -4,031.16%
2014 $-0.06 125.31%
2013 $-0.02 64.43%
2012 $-0.01 98.67%
2011 $-0.01 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$30.27 -4,246.58%
US
$3.09 -522.82%
DE
$34.71 -4,854.79%
US
$1.89 -359.14%
SA
$0.06 -108.38%
MY

Questions about Bionik Laboratories Corp.'s earnings per share (EPS)

What is Bionik Laboratories Corp.'s earnings per share (EPS)?

Bionik Laboratories Corp.'s earnings per share (EPS) over the last twelve months is $-0.73, as of Mar 2023.

What was Bionik Laboratories Corp.'s earnings per share (EPS) in 2023?

In 2023, Bionik Laboratories Corp.'s earnings per share (EPS) was $-0.72, compared with $-1.78 in 2022.

How has Bionik Laboratories Corp.'s earnings per share (EPS) changed since 2018?

From 2018 to 2023, Bionik Laboratories Corp.'s earnings per share (EPS) was highest in 2023 ($-0.72) and lowest in 2018 ($-21.88).

How does Bionik Laboratories Corp.'s earnings per share (EPS) compare with similar companies?

Bionik Laboratories Corp.'s earnings per share (EPS) ($-0.73) is lower than that of all 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with $34.71.